Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

307
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
307
Relative Risk01:12

Relative Risk

550
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
550
Hazard Rate01:11

Hazard Rate

217
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
217
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

350
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
350
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

659
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
659
Actuarial Approach01:20

Actuarial Approach

157
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
157

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-analysis of the systemic immune-inflammatory index and in-hospital mortality of COVID-19 patients.

Heliyon·2024
Same author

Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer.

Journal of translational medicine·2024
Same author

Downregulated RBM5 Enhances CARM1 Expression and Activates the PRKACA/GSK3β Signaling Pathway through Alternative Splicing-Coupled Nonsense-Mediated Decay.

Cancers·2024
Same author

Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.

World journal of surgical oncology·2024
Same author

Single-incision versus conventional three-port laparoscopic appendectomy for acute appendicitis: A meta-analysis of randomized controlled trials.

Asian journal of surgery·2024
Same author

Clinical characteristics and prognostic analysis of acute necrotizing encephalopathy of childhood: a retrospective study at a single center in China over 3 years.

Frontiers in neurology·2024

Related Experiment Video

Updated: Oct 19, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Implementation of an Alternative Method for Assessing Competing Risks: Restricted Mean Time Lost.

Hongji Wu, Hao Yuan, Zijing Yang

    American Journal of Epidemiology
    |September 22, 2021
    PubMed
    Summary

    Restricted mean time lost (RMTL) offers a clinically interpretable alternative to hazard ratios for competing-risks data. The proposed RMTL difference (RMTLd) estimator and test demonstrate accurate estimation and robust statistical performance.

    Keywords:
    competing riskshazard ratiohypothesis testingrestricted mean time lostsample sizesurvival analysis

    More Related Videos

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.3K
    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
    06:55

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

    Published on: January 8, 2020

    14.7K

    Related Experiment Videos

    Last Updated: Oct 19, 2025

    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.4K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.3K
    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
    06:55

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

    Published on: January 8, 2020

    14.7K

    Area of Science:

    • Biostatistics
    • Epidemiology
    • Clinical Trials

    Background:

    • Hazard ratios are standard for survival data but have limitations with competing risks.
    • Cause-specific and subdistribution hazard ratios for competing risks have interpretation and model assumption challenges.

    Purpose of the Study:

    • To introduce restricted mean time lost (RMTL) as an interpretable measure for competing-risks data.
    • To propose a novel estimator and statistical test based on the RMTL difference (RMTLd).

    Main Methods:

    • Developed a new estimator for the RMTL difference (RMTLd).
    • Proposed a hypothetical test and sample-size formula based on RMTLd.
    • Evaluated performance through simulations and real-world data analyses.

    Main Results:

    • The RMTLd estimator demonstrated accurate estimation.
    • The RMTLd test exhibited robust statistical performance, including type I error control and statistical power.
    • Example analyses confirmed the RMTLd test's effectiveness.

    Conclusions:

    • RMTLd provides a clinically meaningful and statistically sound alternative for analyzing competing-risks data.
    • Recommend reporting RMTLd alongside hazard ratios, and as a primary outcome if proportional hazards assumptions are violated.